TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$6.16
-0.08 (-1.28%)
As of May 9, 1:41 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 7 41%
Hold 10 59%
Sell 0 0%
Price Target
Analyst Price Target +587.0% upside
Low Target $27.22
Average Target $42.32
High Target $56.32
Current Price $6.16
Current
$6.16
Target
$42.32
$27.22 $42.32 avg $56.32
Scenario Analysis
Bear Case
$27.22
341.9%
Low target
Base Case
$42.32
+587.0%
Avg target
Bull Case
$56.32
+814.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$23.20
-73.4% from high
52-Week Low
$3.51
+75.5% from low
Target vs 52W High
$42.32
+82.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%